Latest News & Features
article
Without patent protection, efforts to commercialise a repurposed drug have little chance for a reasonable return and are unlikely to attract outside investment. Repurposing drugs can be extremely fruitful for companies as long as proper patent protection is in place. There are a few barriers to consider when trying to patent protect repurposed drugs. 8 April 2021
Big Pharma
The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7. 8 April 2021
Medtech
Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised. 6 April 2021
Americas
Pharmaceutical companies defending an antitrust lawsuit have fought back against attempts to get them to disclose confidential information garnered through discovery during the litigation to the US Federal Trade Commission. 6 April 2021
Americas
A recent University of Texas dispute perfectly illustrates the differing role sovereign immunity takes in proceedings at the Patent Trial and Appeal Board and district court, say Simon Roberts, Nitya Anand and Eric Wang of Hogan Lovells. 6 April 2021
Biotechnology
The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain. 6 April 2021
Medtech
Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi 1 April 2021
Americas
The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office. 1 April 2021
Biotechnology
Amgen v Sanofi continues the Federal Circuit’s trend of undermining certain antibody claims, explains Benjamin Pelletier of Haynes and Boone. 1 April 2021
Medtech
In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies. 30 March 2021